Akorn completes acquisition of Hi-Tech Pharmacal
MLex Summary: Pharmaceutical company Akorn announced Thursday that the company has successfully completed its planned $640 million acquisition of Nasdaq-listed rival Hi-Tech Pharmacal.Statement follows in full....To view the full article, register now.
Already a subscriber? Click here to view full article